Date Added: 08/02/2017
Date Updated: 09/02/2017
ER-REBOA Catheter for resuscitative endovascular balloon occlusion of the aorta (REBOA)
Specialties: Cardiovascular disease & vascular surgery - Emergency care
Technology Type: Devices - Procedures
Stage of development: Other
Stage of EAA: Assessment Complete
Resuscitative endovascular balloon occlusion of the aorta (REBOA) offers a small number of trauma patients improved survival with less physiological disturbance than current treatment options such as cross clamping the aorta. Although poor outcomes were noted, treatment with the REBOA may be considered a treatment of last resort for patients with few options.
The ER-REBOATM Catheter received 510k approval from the United States Food and Drug Administration because of its similarity to other legally marketed devices. There are, however, no human studies published on this device. Therefore, the evidence included in this Technology Brief assessed the use of similar technologies to carry out resuscitative endovascular balloon occlusion of the aorta (REBOA).